ObjectiveThis study aims to report the use of the unilateral pectoralis major muscle
flap for the treatment of the sternal wound dehiscence.MethodsA retrospective study including patients who underwent unilateral pectoralis
major muscle flap was performed for the treatment of sternotomy dehiscence
due to coronary artery bypass, valve replacement, congenital heart disease
correction and mediastinitis, between 1997 and 2016. Data from the
epidemiological profile of patients, length of hospital stay, postoperative
complications and mortality rate were obtained.ResultsDuring this period, 11 patients had their dehiscence of sternotomy treated by
unilateral pectoralis major muscle flap. The patients had a mean age of 54.7
years, the mean hospital stay after flap reconstruction was 17.9 days (from
7 to 52 days). In two patients, it was necessary to harvest a flap from the
rectus abdominis fascia, in association with the pectoralis major muscle
flap, to facilitate the closure of the distal wound. In the postoperative
period, seroma discharge from the surgical wound was observed in six
patients, five reported intense pain (temporary), three had partial
cutaneous dehiscence, and two presented granuloma of the incision.ConclusionThe complex wound from sternotomy dehiscences presents itself as a challenge
to surgical teams. Treatment should include debridement of necrotic tissue
and preferably coverage with well-vascularized tissue. We propose that the
unilateral pectoralis major muscle flap is an interesting and low morbidity
option for the reconstruction of sternal wound dehiscences, with proper
sternum stability and satisfactory functional and aesthetic outcomes.
Pyoderma gangrenosum (PG) is a rare painful ulcerative neutrophilic inflammatory skin disease, necessitating a high level of diagnostic suspicion associated with appropriate treatment to avoid progression. Negative pressure wound therapy (NPWT) has been efficiently used in the treatment of different types of wounds. However, the role of NPWT in the management of PG is still controversial, due to the risk of the pathergy phenomenon. In this article, we conducted a systematic review (according
Objective: Due to the similarities of glabrous skin, the plantar region is an excellent donor area for covering complex palmar–plantar wounds. However, taking grafts from the plantar area often results in significant morbidity at the donor site or non-integration of the graft due to the greater thickness of the plantar corneal layer. Method: This is a prospective case series including patients with burns or wounds who have been treated with a dermal graft using the bilaminar ‘trapdoor’ technique. This procedure is used to remove a thin graft from the deep plantar dermis after the partial elevation of the first layer including the entire epidermis and superficial part of the dermis. Results: At the donor area in the four patients in this case series, we observed healing at around 10 days, and absence of hypertrophic scar in all patients. There was complete re-epithelialisation between two and three weeks from the periphery to the centre of the deep dermal graft, and from the glandular epithelium transferred with the graft. During the follow-up, patients presented aesthetic and functional features of glabrous and amelanotic skin, with similar resistance to those of the adjacent areas of the wound in the palmar–plantar region. Conclusion: This technique has some advantages, such as less surgical time, minimal morbidity in the plantar donor area, easy integration of the grafts, and maintenance of the functional and aesthetic properties of glabrous skin both in the plantar donor area and in the palmar–plantar recipient region. Declaration of interest: The authors have no conflicts of interest to declare.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.